Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

The Edit offers a clear initial price comparison. Read the actual billing agreement before enrolling, especially the refill schedule and what happens after clinical services begin.

$169/month advertisedEvaluation, supplies and shipping listed; review agreement
Subcutaneous injectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Monthly injection price published
  • Supplies and ongoing care listed
  • Public cancellation and refund policies

What to weigh

  • Accepted agreement governs billing details
  • No prorated refund for a started billing period
  • Prescription products generally final sale

A straightforward headline with a second document to read

The Edit makes the first comparison easy: its public sermorelin offer is an injection program with a monthly price rather than an unexplained vial charge. That is a useful starting point for budgeting. It is not the last step, because the policy says the agreement accepted before care controls the details.

I would read those two pieces together. The product page tells you why the service might fit; the agreement tells you what you are authorizing. If the proposed billing interval differs from the monthly presentation, ask for the complete charge and an explanation before consenting. A short written answer can prevent confusion when the first refill approaches.

Look at the whole package

Medication, supplies, evaluation, ongoing care, messaging and temperature-controlled shipping appear together in the advertised package. That makes this a more useful comparison than medication-only pricing, provided the final order includes what the page describes.

The practical question is how those services work for you. Ask who answers a medication concern, whether another visit would cost extra and how a prescription change affects the next shipment. A list of inclusions cannot show response quality or establish that every future need is covered. I would keep the emphasis on a clear care route rather than count the number of features on the page.

Cancellation stops a future commitment

The cancellation policy describes access continuing until the paid period ends, without a prorated refund for time already underway. Completed consultations and pharmacy-processed medication have additional limits. That makes the point at which you change your mind financially significant.

Before a renewal, check both the billing date and the prescription-processing stage. They may represent different deadlines. A request to stop the next plan does not necessarily reverse an order already being prepared. Save the written cancellation confirmation and ask which specific shipment it covers. This is especially useful if the clinician changes the plan while a refill is approaching, when a clinical message and an administrative request may need separate attention.

Resolve the approval wording before payment

The product page uses both a refund-if-declined message and a statement that people who are not approved are not charged. Both aim to reassure an applicant, but they describe different payment mechanics. I would ask whether checkout reserves funds, captures a payment or waits until after the consultation.

The distinction matters if an authorization temporarily reduces available credit or if a refund takes time to arrive. It also separates medical ineligibility from deciding not to continue after care begins. Ask for the terms that apply to your circumstance rather than interpreting a brief reassurance as an unrestricted money-back promise. The published prescription refund policy addresses order errors separately from ordinary returns.

Keep the clinical decision separate from the presentation

The site presents sermorelin around recovery, sleep and body composition. Those themes may explain why someone starts researching, but a polished product page cannot determine the cause of a personal concern. The useful consultation begins with what has changed, what has already been evaluated and which outcome would matter to you.

I would ask what would count as a reason to continue, reconsider or stop. Our results timeline discussion can help prepare that conversation. A provider’s suggested timetable should be treated as something to discuss, not a forecast you can buy. Neither convenience nor an automated refill is evidence that ongoing treatment remains appropriate.

Where The Edit fits

The Edit belongs on a shortlist for someone seeking a clearly presented injection package and comfortable managing recurring care. Its strongest practical feature is the visible package price. Its main qualification is the need to read the agreement behind the simple presentation and make sure the amount, refill interval and cancellation effect match your expectations.

I would compare one actual offer from The Edit with one alternative over the same period, including any separate testing or follow-up that your clinician recommends. This review reflects public information checked in October 2026, not personal treatment or an assessment of clinical performance. Compounded sermorelin is not FDA-approved. A clear price can help select a service to investigate; it does not establish that the medication is appropriate.

Common questions

What does The Edit advertise for sermorelin?

$169 per month for its injection program. Confirm the final supply and billing agreement before proceeding.

Is cancellation the same as a refund?

No. Its policy says cancellation takes effect after the paid period and generally does not refund a period already begun.

Can prescription medication be returned?

The refund policy treats prescription products as final sale, with a separate process for damaged, defective or incorrect orders.

Explore The Edit

See the current offer and decide whether you want to start a consultation.

Visit The Edit

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider prices and terms may change.

  1. The Edit website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement